Find News

Filter articles

Applied Filters

Showing 1 to 10 of 713 results

Jazz Pharma buys clinical-stage biotech company

Ireland14-08-2019Sarah Morgan

Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million.

Bayer buys BlueRock to build cell therapy expertise

Germany, US09-08-2019Sarah Morgan

Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.

NHS to receive £250m for new AI lab

UK08-08-2019Saman Javed

The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

Fed Circ backs ITC on E. coli patent dispute

US07-08-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit yesterday, August 6, affirmed a US International Trade Commission decision to uphold a patent related to E. coli bacteria.

Exact Sciences and Genomic Health in $2.8bn merger

US31-07-2019Rory O'Neill

Exact Sciences will acquire Genomic Health in a merger deal worth $2.8 billion.

Federal Circuit dismisses Amgen’s Neulasta appeal


California-based Amgen is barred from succeeding on its patent infringement claim against Coherus Biosciences, according to the US Court of Appeals for the Federal Circuit.

Sigma-Aldrich submits CRISPR petition at USPTO

US23-07-2019Sarah Morgan

Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.

EU invests €35m into AI cancer diagnostics

EU10-07-2019Sarah Morgan

The European Commission has pledged €35 million to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence.

Cancer Research UK partners with VC firm in $25m deal


Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.

Carpmaels & Ransford name two new partners


Carpmaels & Ransford has appointed two life sciences attorneys as partners, effective yesterday, July 1.

Showing 1 to 10 of 713 results